20. November 2009 02:41
Research and Markets (http://www.researchandmarkets.com/research/410c60/radiopharmaceutica) has announced the addition of the "Radiopharmaceuticals - A US and European Market Analysis" report to their offering.
[More]
695b9412-1af5-4d8a-a9fc-d0801585eab5|0|.0
Posted in: Pharmaceutical News
Tags: Antibody, Brain, Brain Cancer, Cancer, Cell, Ciprofloxacin, Follicular Lymphoma, Lung Cancer, Lymphoma, Nephrology, Neurology, Nuclear Medicine, Oncology, Radiation Therapy, Radiotherapy, Zevalin
20. November 2009 00:55
Two female brain tumor patients have become the first people in the south of England to be treated using a faster form of radiotherapy that extends more advanced care to more patients. RapidArc technology from Varian Medical Systems (NYSE: VAR) makes it possible to deliver image-guided IMRT (intensity modulated radiotherapy) two to eight times faster than is possible with conventional IMRT.
[More]
19. November 2009 04:02
Recent advances in cancer therapeutics have led to the discovery of biomarkers that can predict patient response to certain drugs. Screening for mutations in the epidermal growth factor receptor (EGRF) prior to non-small cell lung cancer treatment, for example, has been shown to indentify patients who are likely to respond to treatment with erlontinib. This maximizes the drug's impact, and spares patients who are not likely to benefit from being subjected to potentially debilitating side effects.
[More]
50ccea28-a9bb-4b4c-9116-c045d0269177|0|.0
Posted in: Medical Science News | Medical Condition News
Tags: Biomarker, Breast Cancer, Cancer, Cell, Cell Proliferation, Cervical Cancer, Colon Cancer, Head and Neck Cancer, Lung Cancer, Melanoma, Non-Small Cell Lung Cancer, Oncogene, Ovarian Cancer, Radiotherapy, Renal Cell Carcinoma, Small Cell Lung Cancer, Sorafenib, Tamoxifen, VEGF
19. November 2009 02:27
Individualised radiotherapy treatment based on a person’s genetic make up could soon become a reality, according to Breast Cancer Campaign.
[More]
19. November 2009 02:11
Varian Medical Systems, Inc., a premier supplier of X-ray tubes and flat panel digital image detectors, will exhibit its PaxScan digital image detectors and its line of X-ray tubes for fluoroscopy, angiography, cardiology and cone-beam CT imaging at the MEDICA 2009 International Trade Fair in Dusseldorf, Germany from November 18-21, 2009.
[More]
19. November 2009 00:22
Exelixis, Inc. today reported interim data from an ongoing phase 1 dose-escalation trial of XL147 (SAR245408) in combination with the EGFR inhibitor erlotinib in patients with advanced solid tumors.
[More]
9f19f465-9b09-4558-8717-5dc5f9c0f5b8|0|.0
Posted in: Drug Trial News | Pharmaceutical News
Tags: Anorexia, Biopsy, Biotechnology, Cancer, Cell, Cell Proliferation, Chemotherapy, Colorectal Cancer, Diarrhea, Erlotinib, Head and Neck Cancer, Hepatocellular Carcinoma, Lung Cancer, Nausea, Non-Small Cell Lung Cancer, Pfizer, Radiotherapy, Small Cell Lung Cancer, Squamous Cell Carcinoma, Vomiting
18. November 2009 03:30
As part of the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Thompson will moderate a press conference on emerging treatments in pancreatic cancer on Tuesday, Nov. 17, 2009, in Room 202 of the Hynes Convention Center in Boston, Mass., from 1:00 p.m. to 2:00 p.m. ET.
[More]
a8f28545-1bf2-426a-9fe3-eefc360e22ae|0|.0
Posted in: Medical Condition News
Tags: Abraxane, Angiogenesis, Antibody, Avastin, Bevacizumab, Blood Vessel, Cancer, Cell, Chemotherapy, Dermatology, Gemcitabine, Gemzar, Gene Expression, Hospital, Liver Cancer, Metastasis, microRNA, Nanotechnology, Oncology, Paclitaxel, Pancreatic Cancer, Pathology, Photodynamic Therapy, Radiotherapy, VEGF
18. November 2009 03:04
Aeolus Pharmaceuticals, Inc. announced today the initiation of a study to test the anti-tumor effects of AEOL 10150 when combined with radiation and chemotherapy in nude mice bearing human non-small cell lung cancer (NSCLC) xenografts.
[More]
9cc6e5d3-b581-4e45-8159-6d64d2a5c2da|0|.0
Posted in: Medical Science News | Medical Condition News | Pharmaceutical News
Tags: Angiogenesis, Anti-Inflammatory, Antioxidant, Cancer, Cell, Chemotherapy, Epilepsy, Fibrosis, Hypoxia, Lung Cancer, Macrophage, Manganese, Non-Small Cell Lung Cancer, Oxidative Stress, Paclitaxel, Radiation Exposure, Radiation Therapy, Radiotherapy, Small Cell Lung Cancer, Stress, Toxicology, VEGF, Weight Loss
17. November 2009 05:02
To highlight results of more recent research, the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International Conference will host a press briefing on "Drugs in the Pipeline." Sara A. Courtneidge, Ph.D., D.Sc., professor and director of the Tumor Microenvironment Program, and director of academic affairs at the Burnham Institute for Medical Research, will moderate this press briefing.
[More]
ac48c877-eb35-45fc-9d99-0eb9b9d6de31|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Acetylation, Adenosine, Amino Acid, Anemia, Angiogenesis, Autophagy, Blood Pressure, Breast Cancer, Cancer, Cediranib, Cell, Chemotherapy, Colorectal Cancer, Diarrhea, DNA, Gene Expression, Hematology, Leukemia, Myeloid Leukemia, Nausea, Oncology, Ovarian Cancer, Radiotherapy, Stem Cell, Stress, Vomiting
16. November 2009 09:21
The American Society of Clinical Oncology (ASCO) has once again recognized Erbitux® (cetuximab) as one of the major clinical cancer advances of 2009. This year Erbitux was selected by ASCO for providing the first significant increase in survival for 30 years in the treatment of patients with 1st-line recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).
[More]
f2838858-9c45-4eb8-a649-a6b5654e9bab|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Acne, Antibody, Cancer, Cell, Cetuximab, Chemotherapy, Colorectal Cancer, Endocrinology, Fertility, Glioblastoma, Head and Neck Cancer, Hypersensitivity, Infertility, Irinotecan, Liposome, Lung Cancer, Metformin, Monoclonal Antibody, Multiple Sclerosis, Non-Small Cell Lung Cancer, Oncology, Oxaliplatin, Radiotherapy, Small Cell Lung Cancer, Smoking, Squamous Cell Carcinoma, Vaccine
13. November 2009 10:10
New software advances for the ATLAS® Corneal Topography System were released today by Carl Zeiss Meditec during the American Academy of Optometry meeting in Orlando, Florida. Review Software and MasterFit II™ Contact Lens Software for the ATLAS corneal topography system are designed to make clinical data and images more accessible for eye care providers, while facilitating improved eye care diagnosis and treatment solutions for patients.
[More]
11. November 2009 01:51
Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.
[More]
1b5117db-1e00-402b-9f30-3052db1f8ace|2|5.0
Posted in: Medical Science News | Medical Condition News
Tags: Antibody, Brain, Brain Cancer, Brain Tumor, Breast Cancer, Cancer, Chemotherapy, Glioblastoma, Lung Cancer, Macrophage, Pharmacology, Radiation Therapy, Radiotherapy
11. November 2009 00:24
A potential new drug for lung cancer has eliminated tumours in 50% of mice in a new study published today in the journal Cancer Research. In the animals, the drug also stopped lung cancer tumours from growing and becoming resistant to treatment. The authors of the research, from Imperial College London, are now planning to take the drug into clinical trials, to establish whether it could offer hope to patients with an inoperable form of lung cancer.
[More]
2a9c5c1b-a300-4337-9787-61d952dfe335|0|.0
Posted in: Medical Science News | Medical Condition News
Tags: Apoptosis, Cancer, Cell, Cell Proliferation, Chemotherapy, Cisplatin, DNA, Growth Hormone, Lung Cancer, Oncology, Radiotherapy, Small Cell Lung Cancer
4. November 2009 04:09
Fox Chase Cancer Center researchers report that radiation therapy alone can reduce prostate specific antigen (PSA) levels below detectable amounts in prostate cancer patients. Patients who have an undetectable level of PSA after therapy have less chance of biochemical failure than other patients and a good chance of being cured.
[More]
4. November 2009 03:13
Obesity, not the amount of radiation given, is the greatest factor in whether early-stage lung cancer patients develop chest wall pain after receiving stereotactic body radiation therapy to the chest wall, with obese patients being more than twice as likely to develop chronic pain compared to those who have less body weight, according to a first-of-its-kind study presented Tuesday, November 3, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).
[More] 
Subscribe